VIRGINIA EILEEN SANDERS, M.D.
Medical Practice at Sand Point Way, Seattle, WA
License number
Washington MD 60467942
Category
Medical Practice
Type
Pediatrics
Address
Address
4800 Sand Point Way NE #M1-13, Seattle, WA 98105
Phone
(206) 987-8232
(206) 985-3201 (Fax)
(206) 985-3201 (Fax)
Professional information
Dr. Virginia E Sanders, Seattle WA - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
4800 Sand Point Way NE STE A-5950, Seattle 98105
(206) 296-4765 (Phone)
850 Republican St, Seattle 98109
(206) 296-4765 (Phone)
850 Republican St, Seattle 98109
Languages:
English
Education:
Medical School
Brown University / Alpert Medical School
Graduated: 2011
Brown University / Alpert Medical School
Graduated: 2011
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease
US Patent:
7763747, Jul 27, 2010
Filed:
Nov 4, 2008
Appl. No.:
12/264858
Inventors:
Alan D. Snow - Lynnwood WA, US
Beth P. Nguyen - Bothell WA, US
Gerardo M. Castillo - Seattle WA, US
Virginia J. Sanders - Seattle WA, US
Thomas P. Lake - Snohomish WA, US
Lesley Larsen - Dundein, NZ
Rex T. Weavers - Dundein, NZ
Stephen D. Lorimer - Dundein, NZ
David S. Larsen - Dundein, NZ
David L. Coffen - San Diego CA, US
Charlotte Coffen, legal representative - Belcamp MD, US
Beth P. Nguyen - Bothell WA, US
Gerardo M. Castillo - Seattle WA, US
Virginia J. Sanders - Seattle WA, US
Thomas P. Lake - Snohomish WA, US
Lesley Larsen - Dundein, NZ
Rex T. Weavers - Dundein, NZ
Stephen D. Lorimer - Dundein, NZ
David S. Larsen - Dundein, NZ
David L. Coffen - San Diego CA, US
Charlotte Coffen, legal representative - Belcamp MD, US
Assignee:
Proteotech, Inc. - Kirkland WA
International Classification:
C07C 69/035, C07C 69/21, A61K 31/222, A61K 31/225
US Classification:
560250, 560251, 514548
Abstract:
Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease
US Patent:
7514583, Apr 7, 2009
Filed:
May 30, 2003
Appl. No.:
10/452851
Inventors:
Alan D. Snow - Lynnwood WA, US
Beth P. Nguyen - Bothell WA, US
Gerardo M. Castillo - Seattle WA, US
Virginia J. Sanders - Seattle WA, US
Thomas P. Lake - Snohomish WA, US
Lesley Larsen - Dundein, NZ
Rex T. Weavers - Dundein, NZ
Stephen D. Lorimer - Dundein, NZ
David S. Larsen - Dundein, NZ
Charlotte Coffen, legal representative - Belcamp MD, US
Beth P. Nguyen - Bothell WA, US
Gerardo M. Castillo - Seattle WA, US
Virginia J. Sanders - Seattle WA, US
Thomas P. Lake - Snohomish WA, US
Lesley Larsen - Dundein, NZ
Rex T. Weavers - Dundein, NZ
Stephen D. Lorimer - Dundein, NZ
David S. Larsen - Dundein, NZ
Charlotte Coffen, legal representative - Belcamp MD, US
Assignee:
Proteotech, Inc. - Kirkland WA
International Classification:
C07C 233/75, A61K 31/165
US Classification:
564179, 514622
Abstract:
Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
Compounds, Compositions And Methods For The Treatment Of Amyloid Diseases And Synucleinopathies Such As Alzheimer's Disease, Type 2 Diabetes, And Parkinson's Disease
US Patent:
2009019, Aug 6, 2009
Filed:
Nov 11, 2008
Appl. No.:
12/269017
Inventors:
Alan D. Snow - Lynnwood WA, US
Beth P. Nguyen - Bothell WA, US
Gerardo M. Castillo - Bothell WA, US
Virginia J. Sanders - Seattle WA, US
Thomas P. Lake - Snohomish WA, US
Lesley Larsen - Sawyers Bay, NZ
Rex T. Weavers - Maryhill, NZ
David S. Lorimer - Opoho, NZ
David S. Larsen - Sawyers Bay, NZ
David L. Coffen - San Diego CA, US
Charlotte Coffen - Belcamp MD, US
Stephen D. Lorimer - Opoho, NZ
Beth P. Nguyen - Bothell WA, US
Gerardo M. Castillo - Bothell WA, US
Virginia J. Sanders - Seattle WA, US
Thomas P. Lake - Snohomish WA, US
Lesley Larsen - Sawyers Bay, NZ
Rex T. Weavers - Maryhill, NZ
David S. Lorimer - Opoho, NZ
David S. Larsen - Sawyers Bay, NZ
David L. Coffen - San Diego CA, US
Charlotte Coffen - Belcamp MD, US
Stephen D. Lorimer - Opoho, NZ
International Classification:
A61K 31/17, C07C 233/56, A61K 31/167, C07C 275/34, A61P 25/28
US Classification:
514598, 564158, 514616, 564 52
Abstract:
Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.